Glatiramer Price Comparison
Relapsing forms of multiple sclerosisSafety Rating 8/10
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Research details
Glatiramer — research data
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range20 mg daily or 40 mg three times weekly SC
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Copaxone)
NCAA D1Permitted
Overview
About Glatiramer
Mechanism of action
Random amino acid copolymer modifying immune response to myelin antigens via T-cell modulation
Safety profile
Injection site reactions, post-injection flushing, chest pain, lipoatrophy · Decades of MS use; injection site reactions; post-injection reaction syndrome; excellent long-term safety
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Glatiramer below your target.
Related pages